MedTrace Logo

Cardiac Stunning After Electrical Cardioversion

NCT06752733 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2024-12-31

No results posted yet for this study

Summary

The goal of this observational study is to evaluate cardiac stunning and electrocardiographic parameters through transthoracic echocardiography and 24 hours ECG conducted immediately following electrical cardioversion. The main question it aims to answer is:

Do echocardiographic and electrocardiographic parameters relating to cardiac stunning predict atrial fibrillation (AF) recurrence rates after electrical cardioversion?

Participants will undergo echocardiography and a 24-hour Holter monitoring immediately after electrical cardioversion.

Conditions

  • Atrial Fibrillation (AF)

Interventions

PROCEDURE

electrical cardioversion

synchronized electrical shocks to restore normal sinus rhythm in patients with atrial fibrillation, performed under sedation

Sponsors & Collaborators

  • Korea University Guro Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-20
Primary Completion
2025-08-31
Completion
2026-08-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06752733 on ClinicalTrials.gov